Home Meetings Online CME/CE Clinical Resources EHR/EMR

Regional Conference Los Angeles, CA

Location: Los Angeles, CA
Date: October 29-30, 2014

Meeting Overview

Venue:
Los Angeles Convention Center
Primary Audience:
Primary Care
Credits:
14.25 AMA PRA Category 1 Credits™, 14.25 AAFP, or 14.25 AANP

Registration is now closed for this program.

Earn CME credits in Los Angeles.

As a primary care clinician, you see patients with a broad spectrum of diagnoses, questions, and needs. Spend two days learning alongside your colleagues at
Pri-Med Los Angeles and gain practical clinical pearls that you can apply in your practice the very next day.

Earn up to 14.25 AMA PRA Category 1 Credits™, 14.25 AAFP Prescribed credits, or 14.25 AANP contact hours of continuing education by attending.

Download conference brochure »

 
Pri-Med Show


Quality CME

The Pri-Med Los Angeles CME curriculum has been developed in collaboration with the American College of Physicians to bring you practical, relevant sessions covering the variety of clinical challenges you come across in your daily practice. Learn from experts in their field as they present on:

  • Understanding the Patient with Chronic Comorbid Medical and Psychiatric Conditions
  • Binge Eating Disorder: What, When, Why, and How?*
  • Current Approaches to Infectious Diseases in Primary Care

Learn More

 

Value for Your Time

Your schedule is busier than ever, so get the most out of your time away from your practice.

  • The convenient location means less time traveling and more time with your patients
  • Enjoy complimentary registration, plus coffee, light breakfast, and a boxed lunch on us
  • Earn up to 14.25 AMA PRA Category 1 Credits™, 14.25 Prescribed credits, or 14.25 AANP contact hours of continuing education credits

Learn More



Who Should Attend

Actively practicing primary care clinicians who are interested in timely, in-depth CME sessions to extend their learning and benefit their patients.

  • Primary care physicians
  • Nurse practitioners
  • Physician assistants
 

Industry-Sponsored Opportunities

Continue your learning during session breaks with these non-CME opportunities:

  • Attend Presentation Theaters covering the latest drugs and therapies
  • Visit the Product Forum and meet face-to-face with local industry representatives

Learn More

All Presentation Theater tickets will be distributed on-site.

Connect on Social Media

Stay in the know on upcoming programs, online offerings, and special promotions by connecting with
Pri-Med through social media:

Facebook  Twitter  LinkedIn  YouTube
Curriculum developed in collaboration
with the American College of Physicians

Curriculum developed in collaboration with the ACP

Sessions & Syllabus

See below for session summaries.
Print Syllabus
Wednesday, October 29, 2014
6:45 AM-7:30 AM
Registration and Breakfast
7:30 AM-7:45 AM
Opening Remarks
7:45 AM-8:45 AM
High Value Care: Informed Decisions that Reduce Waste and Improve Health Outcomes
This interactive session uses real patient cases to challenge clinicians to balance potential benefits with harms and costs of specific medical interventions

Learning Objectives:

  1. Weigh the expected clinical benefits against the costs/harms of testing and therapy when considering patient management choices.
  2. Estimate "out-of-pocket" patient expenses based on insurance status, type of plan and setting of care
Cheryl W O'Malley MD, FACP (Read Bio) Assistant Professor of Medicine, Internal Medicine, University of Arizona College of Medicine, Tucson, AZ, Program Director, Internal Medicine, Internal Medicine Residency Program, Banner Good Samaritan Medical Center, Phoenix, AZ
8:45 AM-10:00 AM
*Binge Eating Disorder: What, When, Why, and How?

Learning Objectives:

  1. Describe diagnostic criteria for binge eating disorder (BED) and discuss common conditions with which BED comorbidly occurs.
  2. Implement improved screening for BED into daily practice among at-risk patients.
  3. Integrate evidence-based treatment strategies for BED, including pharmacologic and non-pharmacologic interventions.
Charles P Vega MDHealth Sciences Clinical Professor, Department of Family Medicine, University of California, Irvine, Irvine, CA
Tracy S Cummings MDAdjunct Instructor, University of Cincinnati, Cincinnati, OH, Psychiatrist, Lindner Center of HOPE, Mason, OH
10:00 AM-11:00 AM
Refreshment Break and Additional Opportunities
11:00 AM-12:30 PM
*Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014

Learning Objectives:

  1. Implement treatment regimens for patients with type 2 diabetes in accordance with recently updated treatment recommendations.
  2. Review the clinical evidence for the use of incretin-based therapies in type 2 diabetes management.
Javier Morales MD (Read Bio) Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY
Jeff Unger MDMedical Director, The Unger Primary Care Medical Center, Chino, CA
Richard B. Aguilar MDMedical Director, Diabetes Nation LLC, Seville Medical Center,
12:30 PM-1:30 PM
Lunch and Additional Opportunities
1:30 PM-2:45 PM
*Clinical Significance and Treatment of Hypertriglyceridemia: Overcoming Challenging Patient Cases

Learning Objectives:

  1. Assess patients with elevated triglycerides for risks of cardiovascular disease and/or pancreatitis.
  2. Explain the importance of managing both LDL-C and non-HDL-C in patients with elevated triglycerides.
  3. Diagnose secondary causes of hypertriglyceridemia
  4. Develop treatment plans for patients with elevated triglycerides to achieve LDL-C and non-HDL-C targets both through lifestyle modification and drug therapy.
  5. Assess the benefits and risks of emerging therapeutic approaches for the management of hypertriglyceridemia
Paul D Rosenblit MD, PhD, FACE, FNLA (Read Bio) Clinical Professor, Medicine, Endocrinology, Diabetes, & Metabolism, University of California, Irvine, School of Medicine, Irvine, CA, Co-Director, Diabetes Out-Patient Clinic, UC Irvine Medical Center, Orange, CA, Hoag Memorial-Newport Beach, St Josephs-Orange, Huntington Beach Hospital, Orange Coast Memorial, Fountain Valley, CA
Eliot A. Brinton MD, FAHA, FNLA (Read Bio) Director, Atherometabolic Research, Utah Foundation for Biomedical Research, Salt Lake City, UT
2:45 PM-3:00 PM
Afternoon Break
3:00 PM-4:00 PM
Managing Common Issues in Menopausal Women
Examine the latest evidence regarding potential benefits/harms of drugs and supplements, especially as they relate to cardiovascular health, that are frequently used by menopausal women

Learning Objectives:

  1. Examine the latest evidence regarding potential benefits and harms of drugs and supplements used by menopausal women, especially as they relate to cardiovascular health.
  2. Tailor therapy according to risks versus benefits of available treatment interventions.
Chrisandra Shufelt MD, MS, FACP (Read Bio) Associate Director, Barbra Streisand Women’s Heart Center, & Preventive and Rehabilitative Cardiac Center, Director, Women’s Hormone and Menopause Program, Assistant Professor, Cedars-Sinai Medical Center, Los Angeles, CA
4:00 PM-5:15 PM
Current Approaches to Infectious Diseases in Primary Care
Hear the latest developments in the war against antimicrobial resistance and recommendations for treating outpatient infections

Learning Objectives:

  1. Effectively assess and diagnose patients with common community-acquired infections.
  2. Apply the latest guideline recommendations for appropriate treatment of pharyngitis, urinary tract infection, and cellulitis.
Fred Lopez MD, MACP (Read Bio) Richard Vial Professor and Vice Chair, Louisiana State University Department of Medicine LSU Health Sciences Center, New Orleans, LA
Thursday, October 30, 2014
6:45 AM-7:30 AM
Registration and Breakfast
7:30 AM-7:45 AM
Opening Remarks
7:45 AM-8:45 AM
Optimizing the Management of Patients with Chronic Kidney Disease
Address the challenges of patients with mild to moderate CKD with respect to slowing disease progression and treating blood chemistry abnormalities

Learning Objectives:

  1. Understand the impact of chronic kidney disease (CKD) as a common condition of the adult US population
  2. Apply the latest evidence-based recommendations for diagnosis and management of patients with stages 1-3 CKD
  3. Slow CKD progression by treating risk factors such as hypertension and diabetes
Richard Lafayette MD, FACPAssociate Professor, Department of Medicine, Director, Stanford Glomerular Disease Center, Clinical Chief, Division of Nephrology, Stanford University School of Medicine, Stanford, CA
8:45 AM-10:00 AM
*A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes

Learning Objectives:

  1. Apply strategies to individualize glycemic targets in patients with type 2 diabetes.
  2. Discuss the limitations of frequently used conventional therapies for the treatment of patients with type 2 diabetes.
  3. Outline the risk factors and clinical consequences of hypoglycemia.
  4. Implement strategies to minimize hypoglycemia risk in the treatment of patients with type 2 diabetes.
Jessica Castle MDAssistant Professor, Oregon Health & Science University, Portland, OR
Andrew Ahmann MD, MSProfessor of Medicine, Director, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR
10:00 AM-11:00 AM
Refreshment Break and Additional Opportunities
11:00 AM-12:15 PM
*A Focus on Bipolar Depression: Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes

Learning Objectives:

  1. Discuss clinically relevant pathophysiology of bipolar disorder, including epidemiologic and mechanistic relationships with cardiometabolic disturbances.
  2. Identify patients with bipolar depression based on comprehensive patient histories, risk factors, key presenting symptoms, and the latest diagnostic criteria.
  3. Tailor therapeutic regimens for bipolar depression to reflect efficacy, safety, and tolerability of approved agents and common patient comorbidities.
  4. Engage patients with bipolar depression to motivate active participation in ongoing care and improve treatment adherence.
Joseph Calabrese MDProfessor, Department of Psychiatry, Director, Mood Disorders Program, University Hospitals Case Medical Center, Case Western Reserve University of Medicine, Cleveland, OH
William Clay Jackson MDClinical Assistant Professor of Psychiatry & Family Medicine, University of Tennessee College of Medicine, Memphis, TN, President, Medical Director, Comprehensive Primary Care, Memphis, TN, Medical Director, Methodist Alliance Hospice and Palliative Services, Memphis, TN
12:15 PM-1:15 PM
Lunch and Additional Opportunities
1:15 PM-2:30 PM
*Modern Obesity Management: Incorporating Pharmacotherapy Into An Integrated Treatment Plan

Learning Objectives:

  1. Discuss pathways of weight control, including satiety signaling as a means to combat obesity.
  2. Discuss the effect of overweight and obesity on the risk for comorbidities and increased mortality.
  3. Assess communication and counseling strategies that can be incorporated into patient encounters in order to address overweight/obesity treatment challenges.
  4. Appraise clinical data for pharmacologic agents available for obesity treatment and design/ develop treatment plans based on individual needs and factors.
Donna H. Ryan MD (Read Bio) Professor Emeritus, Pennington Biomedical Research Center, Baton Rouge, LA
Ken Fujioka MD (Read Bio) Director of the Center for Weight Management, Department of Endocrine, Scripps Clinic, El Cajon, CA
2:30 PM-2:45 PM
Afternoon Break
2:45 PM-3:45 PM
Brain Game 2014
Tough Questions Patients Bring to You

Learning Objectives:

  1. Compete in the popular yet practical medical knowledge game. New categories are sure to provide a fun challenge.
Pamela R. Kushner MA, MD, FAAFP (Read Bio) Clinical Professor, Department of Family Medicine, University of California, Irvine, Irvine, CA
John B. Bundrick MD (Read Bio) Assistant Professor of Medicine, Mayo Clinic College of Medicine, Rochester, MN, Consultant in Medicine, Mayo Clinic, Rochester, MN
3:45 PM-5:00 PM
Hot Off the Press and Into Your Practice

Learning Objectives:

  1. Consider key findings from important new studies that can change your patient care.
Leonard Fromer MD, FAAFP, ABFM (Read Bio) Assistant Clinical Professor, Department of Family Medicine, UCLA School of Medicine, Los Angeles, CA, Executive Medical Director, Group Practice Forum, Los Angeles, CA

Ticketed Events

All Presentation Theater tickets will be distributed on-site.

Morning Break

Non-CME Presentation Theater

10:10 AM-10:55 AM

Obesity

10:10 AM-10:55 AM

Atrial Fibrillation/Stroke

Lunch Break

Non-CME Presentation Theater

12:40 PM-1:25 PM

Diabetes

12:40 PM-1:25 PM

Vaccines

Afternoon Break

Morning Break

Non-CME Presentation Theater

10:10 AM-10:55 AM

Diabetes

10:10 AM-10:55 AM

Rheumatology

Lunch Break

Non-CME Presentation Theater

12:25 PM-1:10 PM

Vaccines

12:25 PM-1:10 PM

Helicobacter pylori

CLOSE  X  
Addressing Chronic Weight Management With Targeted Pharmacotherapy
Brought to you by: Eisai, Inc..
Room: Room 515A
Faculty:
  1. Ted Okerson, MD, FACP, FTOS
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Brought to you by: Janssen Pharmaceuticals, Inc.
Room: Room 515B
Faculty:
  1. Alan Jacobson, FACC , MD
CLOSE  X  
Advancing Paradigm Changes in Type 2 Diabetes Management
Brought to you by: Janssen Pharmaceuticals, Inc.
Room: Room 515B
This program will cover the following topics regarding a sodium-glucose co-transporter (SGLT2) inhibitor: the role of the kidney in regulation of hyperglycemia in T2DM, the mechanism of action - mediated inhibition of SGLT2 in the proximal convoluted tubule of the kidney, key efficacy and safety data from 2 active-controlled clinical trials, important safety information, question and answer session. This promotional educational activity is sponsored by Janssen Pharmaceuticals, Inc. It is not certified for continuing medical education. 010034-140210
Faculty:
  1. Eden Miller, DO
CLOSE  X  
Pneumococcal Disease in Adults: Key Considerations for Your Office, Hospital, or Pharmacy
Room: Room 515A
Faculty:
  1. Robert Feldman, MD
CLOSE  X  
The Effect of a Once-Weekly Therapy on A1C and Weight Over 3 Years
Room: Room 515B
Faculty:
  1. Michael Cobble, MD
CLOSE  X  
A Joint Specific Biomarker for Diagnosing Arthritis
Room: Room 515A
CLOSE  X  
Pneumococcal Pneumonia and Invasive Disease in Adults: Help Protect Patients Aged 50+ in Your Practice
Brought to you by: Pfizer Inc..
Room: Room 515A
Faculty:
  1. William Ershler, MD
CLOSE  X  
A Case-Based Approach to the Diagnosis and Eradication of Helicobacter pylori Infection
Room: Room 515B

Accreditation

Earn up to 14.25 AMA PRA Category 1 Credits™, 14.25 AAFP Prescribed credits, or 14.25 AANP contact hours of continuing education credits.

Final session schedule is pending.

Credits Type Accreditation Statement Designation Statement
14.25 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
14.25 AAFP This Live activity, Pri-Med Regional Conference, Los Angeles, with a beginning date of 10/29/2014, has been reviewed and is acceptable for up to 14.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
14.25 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 14.25 contact hours of continuing education (which includes 7.250 hours of pharmacology).

Faculty

Cheryl O'Malley, MD, FACP (Read Bio)

Assistant Professor of Medicine, Internal Medicine, University of Arizona College of Medicine, Tucson, AZ
Program Director, Internal Medicine, Internal Medicine Residency Program, Banner Good Samaritan Medical Center, Phoenix, AZ

Presenting on:

Charles Vega, MD

Health Sciences Clinical Professor, Department of Family Medicine, University of California, Irvine, Irvine, CA

Presenting on:

  • Binge Eating Disorder: What, When, Why, and How?
    Wednesday, October 29, 2014, 8:45 AM-10:00 AM

Tracy Cummings, MD

Adjunct Instructor, University of Cincinnati, Cincinnati, OH
Psychiatrist, Lindner Center of HOPE, Mason, OH

Presenting on:

  • Binge Eating Disorder: What, When, Why, and How?
    Wednesday, October 29, 2014, 8:45 AM-10:00 AM

Javier Morales, MD (Read Bio)

Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PC, Great Neck, NY

Presenting on:

  • Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
    Wednesday, October 29, 2014, 11:00 AM-12:30 PM

Jeff Unger, MD

Medical Director, The Unger Primary Care Medical Center, Chino, CA

Presenting on:

  • Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
    Wednesday, October 29, 2014, 11:00 AM-12:30 PM

Richard Aguilar, MD

Medical Director, Diabetes Nation LLC, Seville Medical Center,

Presenting on:

  • Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
    Wednesday, October 29, 2014, 11:00 AM-12:30 PM

Paul Rosenblit, MD, PhD, FACE, FNLA (Read Bio)

Clinical Professor, Medicine, Endocrinology, Diabetes, & Metabolism, University of California, Irvine, School of Medicine, Irvine, CA
Co-Director, Diabetes Out-Patient Clinic, UC Irvine Medical Center, Orange, CA
Hoag Memorial-Newport Beach, St Josephs-Orange, Huntington Beach Hospital, Orange Coast Memorial, Fountain Valley, CA

Presenting on:

  • Clinical Significance and Treatment of Hypertriglyceridemia: Overcoming Challenging Patient Cases
    Wednesday, October 29, 2014, 1:30 PM-2:45 PM

Eliot Brinton, MD, FAHA, FNLA (Read Bio)

Director, Atherometabolic Research, Utah Foundation for Biomedical Research, Salt Lake City, UT

Presenting on:

  • Clinical Significance and Treatment of Hypertriglyceridemia: Overcoming Challenging Patient Cases
    Wednesday, October 29, 2014, 1:30 PM-2:45 PM

Chrisandra Shufelt, MD, MS, FACP (Read Bio)

Associate Director, Barbra Streisand Women’s Heart Center, & Preventive and Rehabilitative Cardiac Center, Director, Women’s Hormone and Menopause Program, Assistant Professor, Cedars-Sinai Medical Center, Los Angeles, CA

Presenting on:

Fred Lopez, MD, MACP (Read Bio)

Richard Vial Professor and Vice Chair, Louisiana State University Department of Medicine LSU Health Sciences Center, New Orleans, LA

Presenting on:

Richard Lafayette, MD, FACP

Associate Professor, Department of Medicine, Director, Stanford Glomerular Disease Center, Clinical Chief, Division of Nephrology, Stanford University School of Medicine, Stanford, CA

Presenting on:

Jessica Castle, MD

Assistant Professor, Oregon Health & Science University, Portland, OR

Presenting on:

  • A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes
    Thursday, October 30, 2014, 8:45 AM-10:00 AM

Andrew Ahmann, MD, MS

Professor of Medicine, Director, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR

Presenting on:

  • A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes
    Thursday, October 30, 2014, 8:45 AM-10:00 AM

Joseph Calabrese, MD

Professor, Department of Psychiatry, Director, Mood Disorders Program, University Hospitals Case Medical Center, Case Western Reserve University of Medicine, Cleveland, OH

Presenting on:

  • A Focus on Bipolar Depression: Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes
    Thursday, October 30, 2014, 11:00 AM-12:15 PM

William Jackson, MD

Clinical Assistant Professor of Psychiatry & Family Medicine, University of Tennessee College of Medicine, Memphis, TN
President, Medical Director, Comprehensive Primary Care, Memphis, TN
Medical Director, Methodist Alliance Hospice and Palliative Services, Memphis, TN

Presenting on:

  • A Focus on Bipolar Depression: Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes
    Thursday, October 30, 2014, 11:00 AM-12:15 PM

Donna Ryan, MD (Read Bio)

Professor Emeritus, Pennington Biomedical Research Center, Baton Rouge, LA

Presenting on:

  • Modern Obesity Management: Incorporating Pharmacotherapy Into An Integrated Treatment Plan
    Thursday, October 30, 2014, 1:15 PM-2:30 PM

Ken Fujioka, MD (Read Bio)

Director of the Center for Weight Management, Department of Endocrine, Scripps Clinic, El Cajon, CA

Presenting on:

  • Modern Obesity Management: Incorporating Pharmacotherapy Into An Integrated Treatment Plan
    Thursday, October 30, 2014, 1:15 PM-2:30 PM

Pamela Kushner, MA, MD, FAAFP (Read Bio)

Clinical Professor, Department of Family Medicine, University of California, Irvine, Irvine, CA

Presenting on:

John Bundrick, MD (Read Bio)

Assistant Professor of Medicine, Mayo Clinic College of Medicine, Rochester, MN
Consultant in Medicine, Mayo Clinic, Rochester, MN

Presenting on:

Leonard Fromer, MD, FAAFP, ABFM (Read Bio)

Assistant Clinical Professor, Department of Family Medicine, UCLA School of Medicine, Los Angeles, CA
Executive Medical Director, Group Practice Forum, Los Angeles, CA

Presenting on:

  • Hot Off the Press and Into Your Practice
    Thursday, October 30, 2014, 3:45 PM-5:00 PM

Course Directors

Course Directors Information Coming Soon.

Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Los Angeles Convention Center
1201 S Figueroa St
Los Angeles, CA 90015-1308
(213) 741-5369

Hotel Accommodations

Luxe City Center Hotel
1020 S Figueroa St
Los Angeles, CA 90015-1305
Phone: (213) 743-7601

A limited number of rooms have been reserved at the Luxe City Center Hotel. Please call (213) 743-7601 by 10/13/2014 and identify yourself as a Pri-Med attendee to receive the discounted rate of $199.

Company
Exhibitors
Support
Terms
Tel: (877) 477-4633